Does Rallies show Form 4 insider transactions for XTLB?

Yes. Rallies tracks XTLB insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is XTLB research on Rallies investment advice?

No. Rallies provides research, data, and educational context for XTLB. It does not provide personalized investment advice.

XTLB (XTL Biopharmaceuticals Ltd. American Depositary Shares) Stock Analysis - Insider Trades

XTL Biopharmaceuticals Ltd. American Depositary Shares (XTLB) is a publicly traded Healthcare sector company. As of May 21, 2026, XTLB trades at $2.52 with a market cap of $6.39M and a P/E ratio of 0.00. XTLB moved -2.57% today. Year to date, XTLB is +1.34%; over the trailing twelve months it is -43.64%. Its 52-week range spans $2.12 to $10.28. Rallies surfaces XTLB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading XTLB stock inside the company?

Recent XTLB insider activity includes EDELMAN JOSEPH sold 9.60M, EDELMAN JOSEPH sold 24.68M, EDELMAN JOSEPH sold 2.70M, EDELMAN JOSEPH sold 29.74K, and EDELMAN JOSEPH sold 400.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

XTLB Key Metrics

Key financial metrics for XTLB
Metric	Value
Price	$2.52
Market Cap	$6.39M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$10.28
52-Week Low	$2.12
Volume	6
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Recent XTLB Insider Trades

EDELMAN JOSEPH sold 9.60M (~$1.47M) on Nov 19, 2008.
EDELMAN JOSEPH sold 24.68M (~$3.48M) on Nov 18, 2008.
EDELMAN JOSEPH sold 2.70M (~$412.02K) on Nov 18, 2008.
EDELMAN JOSEPH sold 29.74K (~$4.73K) on Nov 18, 2008.
EDELMAN JOSEPH sold 400.00K (~$64.56K) on Nov 18, 2008.

Latest XTLB News

XTL Biopharmaceuticals to Issue 40% Equity and Raise $1.5M to Acquire Psyga’s GMP Psilocybin Platform — Apr 29, 2026
XTL Biopharmaceuticals to Execute One-for-Four ADS Reverse Split on March 25, 2026 — Mar 20, 2026

XTLB Analyst Consensus

XTLB analyst coverage data. Average price target: $0.00.

Common questions about XTLB

Who is trading XTLB stock inside the company?: Recent XTLB insider activity includes EDELMAN JOSEPH sold 9.60M, EDELMAN JOSEPH sold 24.68M, EDELMAN JOSEPH sold 2.70M, EDELMAN JOSEPH sold 29.74K, and EDELMAN JOSEPH sold 400.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for XTLB?: Yes. Rallies tracks XTLB insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is XTLB research on Rallies investment advice?: No. Rallies provides research, data, and educational context for XTLB. It does not provide personalized investment advice.